Susquehanna International Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.84M | Buy |
348,460
+240,021
| +221% | +$1.95M | ﹤0.01% | 1889 |
|
|
2025
Q1 | $851K | Buy |
108,439
+34,185
| +46% | +$268K | ﹤0.01% | 3594 |
|
|
2024
Q4 | $1.11M | Buy |
74,254
+932
| +1% | +$13.9K | ﹤0.01% | 2841 |
|
|
2024
Q3 | $1.12M | Sell |
73,322
-77,592
| -51% | -$1.19M | ﹤0.01% | 2531 |
|
|
2024
Q2 | $2.3M | Sell |
150,914
-164,137
| -52% | -$2.5M | ﹤0.01% | 1646 |
|
|
2024
Q1 | $5.95M | Buy |
315,051
+198,274
| +170% | +$3.74M | ﹤0.01% | 922 |
|
|
2023
Q4 | $2.23M | Sell |
116,777
-186,865
| -62% | -$3.57M | ﹤0.01% | 1830 |
|
|
2023
Q3 | $5.45M | Sell |
303,642
-73,830
| -20% | -$1.33M | ﹤0.01% | 1032 |
|
|
2023
Q2 | $7.67M | Buy |
377,472
+115,352
| +44% | +$2.34M | ﹤0.01% | 845 |
|
|
2023
Q1 | $4.78M | Buy |
262,120
+180,110
| +220% | +$3.29M | ﹤0.01% | 1145 |
|
|
2022
Q4 | $1.7M | Sell |
82,010
-21,991
| -21% | -$455K | ﹤0.01% | 1745 |
|
|
2022
Q3 | $2.72M | Buy |
104,001
+18,374
| +21% | +$481K | ﹤0.01% | 1359 |
|
|
2022
Q2 | $2.17M | Sell |
85,627
-49,024
| -36% | -$1.24M | ﹤0.01% | 1588 |
|
|
2022
Q1 | $4.25M | Buy |
134,651
+78,124
| +138% | +$2.47M | ﹤0.01% | 1295 |
|
|
2021
Q4 | $2.29M | Buy |
56,527
+1,440
| +3% | +$58.3K | ﹤0.01% | 1827 |
|
|
2021
Q3 | $1.92M | Buy |
55,087
+19,033
| +53% | +$664K | ﹤0.01% | 2009 |
|
|
2021
Q2 | $990K | Buy |
36,054
+12,546
| +53% | +$344K | ﹤0.01% | 2987 |
|
|
2021
Q1 | $660K | Sell |
23,508
-58,209
| -71% | -$1.63M | ﹤0.01% | 3521 |
|
|
2020
Q4 | $2.12M | Sell |
81,717
-6,310
| -7% | -$164K | ﹤0.01% | 1676 |
|
|
2020
Q3 | $1.51M | Buy |
88,027
+77,069
| +703% | +$1.32M | ﹤0.01% | 1712 |
|
|
2020
Q2 | $271K | Buy |
+10,958
| New | +$271K | ﹤0.01% | 3466 |
|
|
2019
Q4 | – | Sell |
-20,271
| Closed | -$184K | – | 4654 |
|
|
2019
Q3 | $184K | Buy |
20,271
+5,350
| +36% | +$48.6K | ﹤0.01% | 3892 |
|
|
2019
Q2 | $119K | Buy |
+14,921
| New | +$119K | ﹤0.01% | 4109 |
|